Vimarsana
Biggest News Aggregation in the World

Page 5 - Eric Lefebvre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Lefebvre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Lefebvre Today - Breaking & Trending Today

Most actively traded companies on the Toronto Stock Exchange | iNFOnews | Thompson-Okanagan's News Source - Vimarsana News

Most actively traded companies on the Toronto Stock Exchange | iNFOnews | Thompson-Okanagan's News Source

TORONTO - Some of the most active companies traded Wednesday on the Toronto Stock Exchange:

Source: infotel.ca
MTY Food Group Tops Profit, Revenue Expectations in 3Q - Vimarsana News

MTY Food Group Tops Profit, Revenue Expectations in 3Q

By Adriano Marchese MTY Food Group Inc. on Wednesday reported a better-than-expected rise in profit and revenue in the third quarter as its recent...

MTY Food Shares Rise as New Acquisitions Continue to Support Earnings, Revenue Beat in 3Q - Vimarsana News

MTY Food Shares Rise as New Acquisitions Continue to Support Earnings, Revenue Beat in 3Q

By Adriano Marchese MTY Food Group shares advanced Wednesday morning after the company said its newest acquisitions have helped drive better-than-expected...

Pliant Therapeutics (NASDAQ:PLRX) Shares Gap Up to $14.58 - Vimarsana News

Pliant Therapeutics (NASDAQ:PLRX) Shares Gap Up to $14.58

Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $14.58, but opened at $15.73. Pliant Therapeutics shares last traded at $17.14, with a volume of 766,465 shares. Wall Street Analyst Weigh In Several equities research analysts have commented on […]

Pliant Therapeutics (NASDAQ:PLRX) Earns Overweight Rating from Cantor Fitzgerald - Vimarsana News

Pliant Therapeutics (NASDAQ:PLRX) Earns Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) in a report published on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $63.00 target price on the stock. A number of other equities research analysts also recently weighed in on the company. HC Wainwright reiterated a buy rating […]